Using portable electrocardiogram devices to assess cardiovascular issues related to pharmacotherapy in Alzheimer's disease patients
The patients presented a median age of 77, with 76% being women, 51% white, 46% presenting MCI, 34% presenting probable AD dementia (ADD) and 20% with no cognitive impairment. Comparisons between the 3 devices did not show statistical differences for QTc (p = 0,412) in ANOVA test and for PRi (p = 0.383), HR (p = 0,159) in Kruskal-Wallis test. Kardia L6 presented a stronger correlation with 12-lead-EKG for PRi(rho = 0.769) and QTc (r = 0,822) and Samsung's device presented a stronger correlation for HR(rho = 0.884) CONCLUSION: This is a preliminary study regarding the use of portable EKG devices to assess cardiovascular issues related to pharmacotherapy in AD. Considering its ease of use, accessibility and accuracy, portable EKG are a promising technology to make decision-making faster and more immediate in remote outpatient settings.
Authors
- Bárbara Lopes Farace (ORCID: https://orcid.org/0000-0002-6172-1093)
- Bernardo de Mattos Viana (ORCID: https://orcid.org/0000-0001-8792-2996)
- Jonas Jardim de Paula (ORCID: https://orcid.org/0000-0001-5530-2346)
- Gabriela Tomé Oliveira Engelmann
- Marco Aurélio Romano‐Silva (ORCID: https://orcid.org/0000-0002-6558-4639)
- Joana Pinto Costa (ORCID: https://orcid.org/0000-0002-4461-4878)
- Joice Coutinho de Alvarenga (ORCID: https://orcid.org/0000-0003-3536-7112)
- Maria Aparecida Camargos Bicalho
- João Vitor da Silva Viana
- Giovanna Correia Pereira Moro
- Leonardo Ryuiti Kimoto
- Júlia de Almeida Barreto
Institutions
- Universidade Federal de Minas Gerais (BR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70858_100005
- Primary Topic
- ECG Monitoring and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00